SPRY
ARS Pharmaceuticals, Inc.
-0.01 (-0.24%)4.16USD584K成交股數413M市值–本益比(近四季)3.5股價營收比+114.2%營收年增(近四季)2026-11-10下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 284K |
| 近 180 天 淨額 | −284K |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-12 | 06-12 | Karas Eric | Chief Commercial Officer | M 選擇權執行 | 25.0K | 1.50 | 38K | 37.2K | SEC |
| 2026-06-12 | 06-12 | Karas Eric | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 25.0K | 10.00 | 250K | 12.2K | SEC |
| 2026-06-12 | 06-12 | Fitzpatrick Alexander A | Chief Legal Officer | S 公開市場賣出(10b5-1) | 3.4K | 10.00 | 34K | 90.9K | SEC |
| 2025-11-13 | 11-14 | Dorsey Brian | Chief Operating Officer | S 公開市場賣出 | 21.8K | 8.71 | 190K | 10.8K | SEC |
| 2025-11-13 | 11-14 | Dorsey Brian | Chief Operating Officer | M 選擇權執行 | 21.8K | 0.64 | 14K | 32.6K | SEC |
| 2025-11-12 | 11-14 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 136K | 8.86 | 1.2M | 0 | SEC |
| 2025-11-12 | 11-14 | Chakma Justin | Chief Business Officer | M 選擇權執行 | 30.0K | 0.84 | 25K | 166K | SEC |
| 2025-11-12 | 11-14 | Shah Pratik | Director | G 贈與 | 100K | – | – | 4.5M | SEC |
| 2025-11-12 | 11-14 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 30.0K | 8.91 | 267K | 136K | SEC |
| 2025-11-12 | 11-14 | Shah Pratik | Director | G 贈與 | 250K | – | – | 4.6M | SEC |
| 2025-08-21 | 08-22 | Scott Kathleen D. | Chief Financial Officer | M 選擇權執行 | 12.5K | 1.50 | 19K | 22.5K | SEC |
| 2025-08-21 | 08-22 | Scott Kathleen D. | Chief Financial Officer | S 公開市場賣出(10b5-1) | 12.5K | 15.00 | 188K | 10.0K | SEC |
| 2025-08-21 | 08-22 | Lowenthal Richard E | PRESIDENT AND CEO | S 公開市場賣出(10b5-1) | 50.0K | 14.49 | 725K | 1.2M | SEC |
| 2025-08-20 | 08-21 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 37.7K | 14.09 | 531K | 1.2M | SEC |
| 2025-08-19 | 08-21 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 12.3K | 14.03 | 173K | 1.3M | SEC |
| 2025-07-01 | 07-03 | Karas Eric | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 15.0K | 16.99 | 255K | 10.3K | SEC |
| 2025-07-01 | 07-03 | Karas Eric | Chief Commercial Officer | M 選擇權執行 | 15.0K | 1.50 | 23K | 25.3K | SEC |
| 2025-06-27 | 07-01 | Deerfield Mgmt IV, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Deerfield Mgmt IV, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Deerfield Private Design Fund IV, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Deerfield Mgmt III, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Deerfield Mgmt III, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Deerfield Private Design Fund III, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Deerfield Private Design Fund III, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Deerfield Private Design Fund IV, L.P. | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Flynn James E | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | Flynn James E | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-27 | 07-01 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | TenPercentOwner | S 公開市場賣出 | 370K | 18.46 | 6.8M | 4.9M | SEC |
| 2025-06-18 | 06-20 | Karas Eric | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 15.0K | 16.00 | 240K | 7.7K | SEC |
| 2025-06-18 | 06-20 | Karas Eric | Chief Commercial Officer | M 選擇權執行 | 15.0K | 1.50 | 23K | 22.7K | SEC |
| 2025-05-20 | 05-22 | Fitzpatrick Alexander A | Chief Legal Officer | M 選擇權執行 | 100K | 5.58 | 558K | 193K | SEC |
| 2025-05-20 | 05-22 | SAUNDERS BRENT L | Director | M 選擇權執行 | 120K | 1.01 | 121K | 120K | SEC |
| 2025-05-20 | 05-22 | Scott Kathleen D. | Chief Financial Officer | S 公開市場賣出 | 50.0K | 14.10 | 705K | 7.4K | SEC |
| 2025-05-20 | 05-22 | Fitzpatrick Alexander A | Chief Legal Officer | S 公開市場賣出 | 103K | 14.10 | 1.5M | 89.6K | SEC |
| 2025-05-20 | 05-22 | Scott Kathleen D. | Chief Financial Officer | M 選擇權執行 | 50.0K | 1.50 | 75K | 57.4K | SEC |
| 2025-05-20 | 05-22 | SAUNDERS BRENT L | Director | S 公開市場賣出 | 120K | 14.25 | 1.7M | 0 | SEC |
| 2025-04-07 | 04-08 | Shawver Laura | Director | M 選擇權執行 | 27.5K | 4.85 | 133K | 260K | SEC |
| 2025-04-07 | 04-08 | Shawver Laura | Director | M 選擇權執行 | 22.5K | 4.85 | 109K | 233K | SEC |
| 2025-04-07 | 04-08 | Shawver Laura | Director | S 公開市場賣出(10b5-1) | 50.0K | 12.30 | 615K | 210K | SEC |
| 2025-03-20 | 03-21 | Karas Eric | Chief Commercial Officer | M 選擇權執行 | 10.0K | 1.50 | 15K | 17.7K | SEC |
| 2025-03-20 | 03-21 | Karas Eric | Chief Commercial Officer | S 公開市場賣出(10b5-1) | 10.0K | 14.00 | 140K | 7.7K | SEC |
| 2025-03-06 | 03-07 | Shawver Laura | Director | S 公開市場賣出(10b5-1) | 49.6K | 11.21 | 556K | 210K | SEC |
| 2025-03-06 | 03-07 | Shawver Laura | Director | M 選擇權執行 | 49.6K | 4.85 | 241K | 260K | SEC |
| 2025-03-05 | 03-07 | Shawver Laura | Director | S 公開市場賣出(10b5-1) | 400 | 11.00 | 4K | 210K | SEC |
| 2025-03-05 | 03-07 | Shawver Laura | Director | M 選擇權執行 | 400 | 4.85 | 2K | 211K | SEC |
| 2025-02-03 | 02-04 | Shawver Laura | Director | M 選擇權執行 | 9.1K | 3.15 | 29K | 219K | SEC |
| 2025-02-03 | 02-04 | Shawver Laura | Director | S 公開市場賣出(10b5-1) | 50.0K | 12.31 | 616K | 210K | SEC |
| 2025-02-03 | 02-04 | Shawver Laura | Director | M 選擇權執行 | 40.9K | 4.85 | 199K | 260K | SEC |
| 2025-01-06 | 01-07 | Shawver Laura | Director | S 公開市場賣出(10b5-1) | 50.0K | 11.10 | 555K | 210K | SEC |
| 2025-01-06 | 01-07 | Shawver Laura | Director | M 選擇權執行 | 50.0K | 3.15 | 158K | 260K | SEC |
| 2024-12-17 | 12-19 | Lowenthal Richard E | PRESIDENT AND CEO | S 公開市場賣出(10b5-1) | 50.0K | 11.67 | 584K | 1.1M | SEC |
| 2024-12-17 | 12-19 | Lowenthal Richard E | PRESIDENT AND CEO | S 公開市場賣出(10b5-1) | 50.0K | 11.67 | 584K | 1.3M | SEC |
| 2024-12-17 | 12-19 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 50.0K | 11.67 | 584K | 1.1M | SEC |
| 2024-12-17 | 12-19 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 50.0K | 11.67 | 584K | 1.3M | SEC |
| 2024-12-13 | 12-13 | Chakma Justin | Chief Business Officer | M 選擇權執行 | 27.3K | 1.44 | 39K | 164K | SEC |
| 2024-12-13 | 12-13 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 27.3K | 12.06 | 329K | 136K | SEC |
| 2024-12-12 | 12-13 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 117K | 12.27 | 1.4M | 136K | SEC |
| 2024-12-12 | 12-13 | Chakma Justin | Chief Business Officer | M 選擇權執行 | 117K | 0.84 | 99K | 254K | SEC |
| 2024-12-12 | 12-13 | Dorsey Brian | Chief Operating Officer | S 公開市場賣出(10b5-1) | 25.0K | 12.30 | 308K | 6.0K | SEC |
| 2024-12-12 | 12-13 | Dorsey Brian | Chief Operating Officer | M 選擇權執行 | 25.0K | 0.64 | 16K | 31.0K | SEC |
| 2024-12-11 | 12-13 | Dorsey Brian | Chief Operating Officer | S 公開市場賣出(10b5-1) | 15.0K | 12.43 | 186K | 6.0K | SEC |
| 2024-12-11 | 12-13 | Dorsey Brian | Chief Operating Officer | M 選擇權執行 | 15.0K | 0.64 | 10K | 21.0K | SEC |
| 2024-12-10 | 12-12 | Chakma Justin | Chief Business Officer | M 選擇權執行 | 50.0K | 0.84 | 42K | 186K | SEC |
| 2024-12-10 | 12-12 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 50.0K | 13.15 | 658K | 136K | SEC |
| 2024-12-10 | 12-11 | Lowenthal Richard E | PRESIDENT AND CEO | S 公開市場賣出(10b5-1) | 50.0K | 13.17 | 659K | 1.2M | SEC |
| 2024-12-10 | 12-11 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 50.0K | 13.16 | 658K | 1.1M | SEC |
| 2024-12-10 | 12-11 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | S 公開市場賣出(10b5-1) | 50.0K | 13.17 | 659K | 1.2M | SEC |
| 2024-12-10 | 12-11 | Lowenthal Richard E | PRESIDENT AND CEO | S 公開市場賣出(10b5-1) | 50.0K | 13.16 | 658K | 1.1M | SEC |
| 2024-12-06 | 12-09 | Lowenthal Richard E | PRESIDENT AND CEO | M 選擇權執行 | 13.8K | 1.44 | 20K | 3.4M | SEC |
| 2024-12-06 | 12-09 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M 選擇權執行 | 13.8K | 1.44 | 20K | 3.4M | SEC |
| 2024-12-06 | 12-09 | Lowenthal Richard E | PRESIDENT AND CEO | M 選擇權執行 | 11.9K | 8.42 | 100K | 4.3M | SEC |
| 2024-12-06 | 12-09 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M 選擇權執行 | 11.9K | 8.42 | 100K | 4.3M | SEC |
| 2024-12-06 | 12-09 | Tanimoto Sarina | CHIEF MEDICAL OFFICER | M 選擇權執行 | 11.9K | 8.42 | 100K | 3.4M | SEC |
| 2024-12-06 | 12-09 | Lowenthal Richard E | PRESIDENT AND CEO | M 選擇權執行 | 11.9K | 8.42 | 100K | 3.4M | SEC |
| 2024-12-06 | 12-06 | Chakma Justin | Chief Business Officer | M 選擇權執行 | 50.0K | 0.84 | 42K | 186K | SEC |
| 2024-12-06 | 12-06 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 50.0K | 14.23 | 712K | 136K | SEC |
| 2024-12-05 | 12-06 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 49.6K | 14.13 | 701K | 136K | SEC |
| 2024-12-05 | 12-06 | Chakma Justin | Chief Business Officer | M 選擇權執行 | 49.6K | 0.84 | 42K | 186K | SEC |
| 2024-12-04 | 12-06 | Chakma Justin | Chief Business Officer | S 公開市場賣出 | 45.0K | 13.95 | 628K | 136K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.9M | 87.0M | 不變 | 持平 |
| Rubric Capital Management LP | 8.5M | 68.4M | +541K (+7%) | 加碼 |
| ORBIMED ADVISORS LLC | 8.3M | 66.4M | 不變 | 持平 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 7.5M | 60.1M | 不變 | 持平 |
| BlackRock, Inc. | 5.3M | 42.5M | +299K (+6%) | 加碼 |
| Tyro Capital Management LLC | 4.5M | 35.7M | +1.5M (+50%) | 加碼 |
| Aberdeen Group plc | 4.2M | 33.4M | +57.0K (+1%) | 加碼 |
| SR One Capital Management, LP | 4.0M | 32.1M | 不變 | 持平 |
| STATE STREET CORP | 3.7M | 29.9M | +85.7K (+2%) | 加碼 |
| Capital World Investors | 2.8M | 22.1M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | 20.5M | +11.0K (+0%) | 加碼 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 2.4M | 19.2M | −3.6M (-60%) | 減碼 |
| UBS Group AG | 1.9M | 15.5M | −321K (-14%) | 減碼 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.7M | 13.6M | +172K (+11%) | 加碼 |
| BOOTHBAY FUND MANAGEMENT, LLC | 1.6M | 12.8M | +1.4M (+539%) | 加碼 |
| GENERAL AMERICAN INVESTORS CO INC | 1.1M | 9.1M | +406K (+56%) | 加碼 |
| Third Point(勒布) Third Point LLC | 1.0M | 8.0M | 不變 | 持平 |
| PEREGRINE CAPITAL MANAGEMENT LLC | 672K | 5.4M | 新進 | 新進 |
| Tejara Capital Ltd | 607K | 4.9M | +397K (+189%) | 加碼 |
| ADAR1 Capital Management, LLC | 601K | 4.8M | −761K (-56%) | 減碼 |
| Pavaki Capital Management LLC | 580K | 4.6M | +3.4K (+1%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 567K | 4.5M | +56.3K (+11%) | 加碼 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 551K | 4.4M | +18.0K (+3%) | 加碼 |
| NORTHERN TRUST CORP | 549K | 4.4M | +19.8K (+4%) | 加碼 |
| LEVIN CAPITAL STRATEGIES, L.P. | 549K | 4.4M | −3.6K (-1%) | 減碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 206 +2 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 38 / 36 / 70 / 52 |
| 機構合計持股 · 佔流通股 | 90.7M · 91.2% |
| 合計季末市值 | 707M |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 23.2M |
|---|---|
| 與上期比 | +1.1% |
| 佔流通股數 | 23.34% |
| 日均成交量 | 1.6M |
| 回補天數 | 14.1 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 23.2M | +1.1% | 23.34% | 1.6M | 14.1 |
| 2026-08-14 | 23.0M | +7.0% | 23.08% | 2.1M | 11.0 |
| 2026-07-31 | 21.5M | -5.4% | 21.57% | 2.8M | 7.8 |
| 2026-07-15 | 22.7M | +4.3% | 22.80% | 1.5M | 15.3 |
| 2026-06-30 | 21.7M | -5.9% | 21.85% | 2.5M | 8.6 |
| 2026-06-15 | 23.1M | -9.4% | 23.22% | 1.3M | 17.6 |
| 2026-05-29 | 25.5M | -1.6% | 25.64% | 1.8M | 14.1 |
| 2026-05-15 | 25.9M | -1.1% | 26.06% | 1.9M | 13.3 |
| 2026-04-30 | 26.2M | -2.1% | 26.34% | 1.7M | 15.1 |
| 2026-04-15 | 26.8M | +5.6% | 26.91% | 1.3M | 21.2 |
| 2026-03-31 | 25.3M | +6.8% | 25.48% | 1.8M | 13.9 |
| 2026-03-13 | 23.7M | +4.3% | 23.85% | 1.3M | 17.9 |
| 2026-02-27 | 22.8M | +2.3% | 22.88% | 704K | 32.3 |
| 2026-02-13 | 22.2M | +3.9% | 22.36% | 1.2M | 18.4 |
| 2026-01-30 | 21.4M | +5.8% | 21.52% | 1.4M | 15.2 |
| 2026-01-15 | 20.2M | -1.4% | 20.34% | 2.2M | 9.4 |
| 2025-12-31 | 20.5M | -5.0% | 20.62% | 1.4M | 14.7 |
| 2025-12-15 | 21.6M | +4.5% | 21.71% | 1.7M | 12.4 |
| 2025-11-28 | 20.7M | +2.6% | 20.78% | 2.6M | 8.0 |
| 2025-11-14 | 20.1M | +1.9% | 20.25% | 2.4M | 8.4 |
| 2025-10-31 | 19.8M | +4.2% | 19.87% | 1.7M | 11.9 |
| 2025-10-15 | 19.0M | -12.6% | 19.07% | 2.6M | 7.3 |
| 2025-09-30 | 21.7M | +0.5% | 21.81% | 2.6M | 8.4 |
| 2025-09-15 | 21.6M | +2.6% | 21.70% | 3.5M | 6.1 |
| 2025-08-29 | 21.0M | +18.4% | 21.16% | 2.6M | 8.1 |
| 2025-08-15 | 17.8M | +15.8% | 17.86% | 1.9M | 9.5 |